Voyager Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Voyager Therapeutics, Inc. (VYGR) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 236.97 thousand shares as of 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2018-11-07
- 2018-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 236.97K shares.
- 2018-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 347.72K shares.
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 557.98K shares.
- 2017-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 676.15K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2018-09-30 | 236.97K shares 10-Q · filed 2018-11-07 |
| 2018-06-30 | 347.72K shares 10-Q · filed 2018-08-07 |
| 2017-12-31 | 557.98K shares 10-Q · filed 2018-11-07 |
| 2017-09-30 | 676.15K shares 10-Q · filed 2017-11-02 |
| 2017-06-30 | 863.43K shares 10-Q · filed 2017-08-08 |
| 2017-03-31 | 997.14K shares 10-Q · filed 2017-05-09 |
| 2016-12-31 | 1.17M shares 10-Q · filed 2017-11-02 |
| 2016-09-30 | 1.30M shares 10-Q · filed 2016-11-10 |
| 2016-06-30 | 1.45M shares 10-Q · filed 2016-08-11 |
| 2016-03-31 | 1.63M shares 10-Q · filed 2016-05-12 |
| 2015-12-31 | 1.82M shares 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |